Functional anthology of intrinsic disorder. 3. Ligands, post-translational modifications, and diseases associated with intrinsically disordered proteins

Journal of Proteome Research

Volumn 6, Issue 5, 2007, Pages 1917-1932

  Xie, Hongbo ^a   Vucetic, Slobodan ^a   Iakoucheva, Lilia M ^b   Oldfield, Christopher J ^c   Dunker, A Keith ^c   Obradovic, Zoran ^a   Uversky, Vladimir N ^c,d  

^a TEMPLE UNIVERSITY   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c INDIANA UNIVERSITY   (United States)

^d INSTITUTE FOR BIOLOGICAL INSTRUMENTATION   (Russian Federation)

Author keywords

Bioinformatics; Disorder prediction; Intrinsic disorder; Intrinsically disordered proteins; Protein function; Protein structure

Indexed keywords

BINDING PROTEIN; LIGAND; MEMBRANE PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALBINISM; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ARTICLE; BIOINFORMATICS; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; HEARING IMPAIRMENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALARIA; NONHUMAN; OBESITY; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DATABASE; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; PROTEOMICS; SWISS-PROT; TRYPANOSOMIASIS;

ANIMALS; COMPUTATIONAL BIOLOGY; DATABASES, PROTEIN; HUMANS; LIGANDS; PROTEIN CONFORMATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINS; SEQUENCE ANALYSIS, PROTEIN;

EUKARYOTA;

EID: 33847783298     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr060394e     Document Type: Article

References (208)

1. Mersfelder, E. L.; Parthun, M. R. The tale beyond the tail: histone core domain modifications and the regulation of chromatin structure. Nucleic Acids Res. 2006, 34, 2653-2662.
2. Grant, P. A. A tale of histone modifications. GenomeBiology 2001, 2, reviews0003.1-reviews0003.6.
3. Goll, M. G.; Bestor, T. H. Histone modification and replacement in chromatin activation. Genes Dev. 2002, 16, 1739-1742.
4. Turner, B. M. Cellular memory and the histone code. Cell 2002, 111, 285-291.
5. Cocklin, R. R.; Wang, M. Identification of methylation and acetylation sites on mouse histone H3 using matrix-assisted laser desorption/ionization time-of-flight and nanoelectrospray ionization tandem mass spectrometry. J. Protein Chem. 2003, 22, 327-334.
6. Zhang, K.; Tang, H.; Huang, L.; Blankenship, J. W.; Jones, P. R.; Xiang, F.; Yau, P. M.; Burlingame, A. L. Identification of acetylation and methylation sites of histone H3 from chicken erythrocytes by high-accuracy matrix-assisted laser desorption ionization-time-of-flight, matrix-assisted laser desorption ionization-postsource decay, and nanoelectrospray ionization tandem mass spectrometry. Anal. Biochem. 2002, 306, 259-269.
7. Zhang, L.; Eugeni, E. E.; Parthun, M. R.; Freitas, M. A. Identification of novel histone post-translational modifications by peptide mass fingerprinting. Chromosoma 2003, 112, 77-86.
8. Stryer, L. Biochemistry; Mir Publishers: Moscow, 1985; Vol. 1.
9. Metzler, D. E. Biochemistry. The Chemical Reactions of Living Cell; Mir Publishers: Moscow, 1980; Vol. 1.
10. Fersht, A. R. Enzyme Structure and Mechanism; Mir Publishers: Moscow, 1980.
11. Ovchinnikov, Y. A. Bioorganic Chemistry, Prosveshchenie: Moscow, 1987.
12. Hoard, J. L. Stereochemistry of porphyrins. In Hemes and Homoproteins; Chance, B., Estabrook, R. W., Yonetani, T., Eds.; Academic Press: New York, 1966; pp 9-24.
13. Perutz, M. F. Stereochemistry of cooperative effects in haemoglobin. Nature 1970, 228, 726-739.
14. Uversky, V. N. A rigidifying union: The role of ligands in protein structure and stability. In Recent Research Developments in Biophysics & Biochemistry, Pandalai, S. G, Ed.; Transworld Research Network: Kerala, India, 2003; pp 711-745.
15. Xie, H.; Vucetic, S.; Iakoucheva, L. M.; Oldfield, C.J.; Dunker, A. K.; Obradovic, Z.; Uversky, V. N. Functional anthology of intrinsic disorder. 1. Biological processes and functions of proteins with long disordered regions. J. Proteome Res. 2007, 5, 1882-1898.
16. Boeckmann, B.; Bairoch, A.; Apweiler, R.; Blatter, M. C.; Estreicher, A.; Gasteiger, E.; Martin, M. J.; Michoud, K.; O'Donovan, C.; Phan, I.; Pilbout, S.; Schneider, M. The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003. Nucleic Acids Res. 2003, 31, 365-370.
17. O'Donovan, C.; Martin, M. J.; Glemet, E.; Codani, J. J.; Apweiler, R. Removing redundancy in SWISS-PROT and TrEMBL. Bioinformatics 1999, 15, 258-259.
18. Enright, A. J.; Van, Dongen, S.; Ouzounis, C.A. An efficient algorithm for large-scale detection of protein families. Nucleic Acids Res. 2002, 30, 1575-1584.
19. Peng, K.; Vucetic, S.; Radivojac, P.; Brown, C.J.; Dunker, A. K.; Obradovic, Z. Optimizing long intrinsic disorder predictors with protein evolutionary information. J. Bioinf. Comput. Biol. 2005, 3, 35-60.
20. Haynes, C.; Iakoucheva, L. M. Serine/arginine-rich splicing factors belong to a class of intrinsically disordered proteins. Nucleic Acids Res. 2006, 34, 305-312.
21. Gutierrez, P.; Osborne, M. J.; Siddiqui, N.; Trempe, J. F.; Arrow-smith, C.; Gehring, K. Structure of the archaeal translation initiation factor aIF2 beta from Methanobacterium thermoautotrophicum: implications for translation initiation. Protein Sci. 2004, 13, 659-667.
22. Longhi, S.; Receveur-Brechot, V.; Karlin, D.; Johansson, K.; Darbon, H.; Bhella, D.; Yeo, R.; Finet, S.; Canard, B. The C-terminal domain of the measles virus nucleoprotein is intrinsically disordered and folds upon binding to the C-terminal moiety of the phosphoprotein. J. Biol. Chem. 2003, 278, 18638-18648.
23. Bourhis, J. M.; Johansson, K.; Receveur-Brechot, V.; Oldfield, C. J.; Dunker, K. A.; Canard, B.; Longhi, S. The C-terminal domain of measles virus nucleoprotein belongs to the class of intrinsically disordered proteins that fold upon binding to their physiological partner. Virus Res. 2004, 99, 157-167.
24. Bourhis, J. M.; Receveur-Brechot, V.; Oglesbee, M.; Zhang, X.; Buccellato, M.; Darbon, H.; Canard, B.; Finet, S.; Longhi, S. The intrinsically disordered C-terminal domain of the measles virus nucleoprotein interacts with the C-terminal domain of the phosphoprotein via two distinct sites and remains predominantly unfolded. Protein Sci. 2005, 14, 1975-1992.
25. Karlin, D.; Ferron, F.; Canard, B.; Longhi, S. Structural disorder and modular organization in Paramyxovirinae N and P. J. Gen. Virol. 2003, 84, 3239-3252.
26. Vasak, M.; Hasler, D. W. Metallothioneins: new functional and structural insights. Curr. Opin. Chem. Biol. 2000, 4, 177-183.
27. Ejnik, J.; Robinson, J.; Zhu, J.; Forsterling, H.; Shaw, C. F.; Petering, D. H. Folding pathway of apo-metallothionein induced by Zn2+, Cd2+ and Co2+. J. Inorg. Biochem. 2002, 88, 144-152.
28. Blindauer, C.A.; Sadler, P. J. How to hide zinc in a small protein. Ace. Chem. Res. 2005, 38, 62-69.
29. Xie, H.; Vucetic, S.; Iakoucheva, L. M.; Oldfield, C.J.; Dunker, A. K.; Obradovic, Z.; Uversky, V. N. Functional anthology of intrinsic disorder. 2. Cellular components, domains, technical terms, developmental processes, and coding sequence diversity associated with long disordered regions. J. Proteome Res. 2007, 5, 1899-1916.
30. Uversky, V. N.; Gillespie, J. R.; Fink, A. L. Why are "natively unfolded" proteins unstructured under physiologic conditions? Proteins 2000, 41, 415-427.
31. Bubb, M. R. Thymosin beta 4 interactions. Vitam. Horm. 2003, 66, 297-316.
32. Filatov, V. L.; Katrukha, A. G.; Bulargina, T. V.; Gusev, N. B. Troponin: structure, properties, and mechanism of functioning. Biochemistry (Moscow) 1999, 64, 969-985.
33. Slupsky, C. M.; Sykes, B. D. NMR solution structure of calcium-saturated skeletal muscle troponin C.Biochemistry 1995, 34, 15953-15964.
34. Heller, W. T.; Abusamhadneh, E.; Finley, N.; Rosevear, P. R.; Trewhella, J. The solution structure of a cardiac troponin C-troponin I-troponin T complex shows a somewhat compact troponin C interacting with an extended troponin I-troponin T component. Biochemistry 2002, 41, 15654-15663.
35. Radivojac, P.; Vucetic, S.; O'Connor, T. R.; Uversky, V. N.; Obradovic, Z.; Dunker, A. K. Calmodulin signaling: analysis and prediction of a disorder-dependent molecular recognition. Proteins 2006, 63, 398-410.
36. Stull, J. T. Ca2+-dependent cell signaling through calmodulin-activated protein phosphatase and protein kinases minireview series. J. Biol. Chem. 2001, 276, 2311-2312.
37. Vetter, S. W.; Leclerc, E. Novel aspects of calmodulin target recognition and activation. Eur. J. Biochem. 2003, 270, 404-414.
38. 15N relaxation using inverse detected two-dimensional NMR spectroscopy: the central helix is flexible. Biochemistry 1992, 31, 5269-5278.
39. Ikura, M.; Barbato, G.; Hee, C.B.; Bax, A. Solution structure of calmodulin and its complex with a myosin light chain kinase fragment. Cell Calcium 1992, 13, 391-400.
40. Ikura, M.; Clore, G. M.; Gronenborn, A. M.; Zhu, G.; Klee, C.B.; Bax, A. Solution structure of a calmodulin-target peptide complex by multidimensional NMR. Science 1992, 256, 632-638.
41. Dunker, A. K.; Garner, E.; Guilliot, S.; Romero, P.; Albrecht, K.; Hart, J.; Obradovic, Z.; Kissinger, C.; Villafranca, J. E. Protein disorder and the evolution of molecular recognition: theory, predictions and observations. Pac. Symp. Biocomput. 1998, 473-484.
42. Mulloy, B.; Linhardt, R. J. Order out of complexity-protein structures that interact with heparin. Curr. Opin. Struct. Biol. 2001, 11, 623-628.
43. Capila, I.; Hernaiz, M. J.; Mo, Y. D.; Mealy, T. R.; Campos, B.; Dedman, J. R.; Linhardt, R. J.; Seaton, B. A. Annexin V-heparin oligosaccharide complex suggests heparan sulfate-mediated assembly on cell surfaces. Structure 2001, 9, 57-64.
44. Cohlberg, J. A.; Li, J.; Uversky, V. N.; Fink, A. L. Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from α-synuclein in vitro. Biochemistry 2002, 41, 1502-1511.
45. Friedhoff, P.; Schneider, A.; Mandelkow, E. M.; Mandelkow, E. Rapid assembly of Alzheimer-like paired helical filaments from microtubule-associated protein tau monitored by fluorescence in solution. Biochemistry 1998, 37, 10223-10230.
46. Paudel, H. K.; Li, W. Heparin-induced conformational change in microtubule-associated protein Tau as detected by chemical cross-linking and phosphopeptide mapping. J. Biol. Chem. 1999, 274, 8029-8038.
47. Headey, S. J.; Keizer, D. W.; Yao, S.; Brasier, G.; Kantharidis, P.; Bach, L. A.; Norton, R. S. C-terminal domain of insulin-like growth factor (IGF) binding protein-6: structure and interaction with IGF-II. Mol. Endocrinol. 2004, 18, 2740-2750.
48. Ovchinnikov, Y. A.; Lipkin, V. M.; Kumarev, V. P.; Gubanov, V. V.; Khramtsov, N. V.; Akhmedov, N. B.; Zagranichny, V. E.; Muradov, K. G. Cyclic GMP phosphodiesterase from cattle retina. Amino acid sequence of the gamma-subunit and nucleotide sequence of the corresponding cDNA. FEBS Lett. 1986, 204, 288-292.
49. Uversky, V. N.; Permyakov, S. E.; Zagranichny, V. E.; Rodionov, I. L.; Fink, A. L.; Cherskaya, A. M.; Wasserman, L. A.; Permyakov, E. A. Effect of zinc and temperature on the conformation of the gamma subunit of retinal phosphodiesterase: a natively unfolded protein. J. Proteome Res. 2002, 1, 149-159.
50. Gerken, T. A. The solution structure of mucous glycoproteins: proton NMR studies of native and modified ovine submaxillary mucin. Arch. Biochem. Biophys. 1986, 247, 239-253.
51. Shanmugam, G.; Polavarapu, P. L. Structures of intact glycoproteins from vibrational circular dichroism. Proteins 2006, 63, 768-776.
52. Hai, T. W.; Liu, F.; Coukos, W. J.; Green, M. R. Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-binding heterodimers. Genes Dev. 1989, 3, 2083-2090.
53. Nagadoi, A.; Nakazawa, K.; Uda, H.; Okuno, K.; Maekawa, T.; Ishii, S.; Nishimura, Y. Solution structure of the transactivation domain of ATF-2 comprising a zinc finger-like subdomain and a flexible subdomain. J. Mol. Biol. 1999, 287, 593-607.
54. McPhee, I.; Gibson, L. C.; Kewney, J.; Darroch, C.; Stevens, P. A.; Spinks, D.; Cooreman, A.; MacKenzie, S. J. Cyclic nucleotide signalling: a molecular approach to drug discovery for Alzheimer's disease. Biochem. Soc. Trans. 2005, 33, 1330-1332.
55. Bos, J. L. Linking Rap to cell adhesion. Curr. Opin. Cell Biol. 2005, 17, 123-128.
56. Dunker, A. K.; Cortese, M. S.; Romero, P.; Iakoucheva, L. M.; Uversky, V. N. Flexible nets. The roles of intrinsic disorder in protein interaction networks. FEBS J. 2005, 272, 5129-5148.
57. Haynes, C.; Oldfield, C.J.; Ji, F.; Klitgord, N.; Cusick, M. E.; Radivojac, P.; Uversky, V. N.; Vidal, M.; Iakoucheva, L. M. Intrinsic disorder is a common feature of hub proteins from four eukaryotic interactomes. PLoS Comput. Biol 2006, 2, e100.
58. Wikstrom, M.; Drakenberg, T.; Forsen, S.; Sjobring, U.; Bjorck, L. Three-dimensional solution structure of an immunoglobulin light chain-binding domain of protein L. Comparison with the IgG-binding domains of protein G. Biochemistry 1994, 33, 14011-14017.
59. Hirabayashi, J.; Kasai, K. The family of metazoan metal-independent beta-galactoside-binding lectins: structure, function and molecular evolution. Glycobiology 1993, 3, 297-304.
60. Dumic, J.; Dabelic, S.; Flogel, M. Galectin-3: an open-ended story. Biochim. Biophys. Acta 2006, 1760, 616-635.
61. Iacobini, C.; Amadio, L.; Oddi, C.; Ricci, C.; Barsotti, P.; Missori, S.; Sorcini, M.; Di Mario, U.; Pricci, F.; Pugliese, G. Role of galectin-3 in diabetic nephropathy. J. Am. Soc. Nephrol. 2003, 14, S264-270.
62. Liu, F. T.; Frigeri, L. G.; Gritzmacher, C.A.; Hsu, D. K.; Robertson, M. W.; Zuberi, R. I. Expression and function of an IgE-binding animal lectin (epsilon BP) in mast cells. Immunopharmacology 1993, 26, 187-195.
63. Birdsall, B.; Feeney, J.; Burdett, I. D.; Bawumia, S.; Barboni, E. A.; Hughes, R. C. NMR solution studies of hamster galectin-3 and electron microscopic visualization of surface-adsorbed complexes: evidence for interactions between the N- and C-terminal domains. Biochemistry 2001, 40, 4859-4866.
64. Nishimura, M.; Yoshida, T.; Shirouzu, M.; Terada, T.; Kuramitsu, S.; Yokoyama, S.; Ohkubo, T.; Kobayashi, Y. Solution structure of ribosomal protein L16 from Thermus thermophilus HB8. J. Mol. Biol. 2004, 344, 1369-1383.
65. Sargent, P. J.; Farnaud, S.; Evans, R. W. Structure/function overview of proteins involved in iron storage and transport. Curr. Med. Chem. 2005, 12, 2683-2693.
66. Imlay, J. A. Iron-sulphur clusters and the problem with oxygen. Mol. Microbiol. 2006, 59, 1073-1082.
67. Mewies, M.; Mclntire, W. S.; Scrutton, N. S. Covalent attachment of flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN) to enzymes: the current state of affairs. Protein Sci. 1998, 7, 7-20.
68. John, R. A. Pyridoxal phosphate-dependent enzymes. Biochim. Biophys. Acta 1995, 1248, 81-96.
69. Neidhart, D. J.; Kenyon, G. L.; Gerlt, J. A.; Petsko, G. A. Mandelate racemase and muconate lactonizing enzyme are mechanistically distinct and structurally homologous. Nature 1990, 347, 692-694.
70. Gerlt, J. A.; Babbitt, P. C.; Rayment, I. Divergent evolution in the enolase superfamily: the interplay of mechanism and specificity. Arch. Biochem. Biophys. 2005, 433, 59-70.
71. ef complex. Biochemistry 2004, 43, 5921-5929.
72. AEvarsson, A.; Seger, K.; Turley, S.; Sokatch, J. R.; Hoi, W. G. Crystal structure of 2-oxoisovalerate and dehydrogenase and the architecture of 2-oxo acid dehydrogenase multienzyme complexes. Nat. Struct. Biol. 1999, 6, 785-792.
73. AEvarsson, A.; Chuang, J. L.; Wynn, R. M.; Turley, S.; Chuang, D. T.; Hol, W. G. Crystal structure of human branched-chain alpha-ketoacid dehydrogenase and the molecular basis of multienzyme complex deficiency in maple syrup urine disease. Structure 2000, 8, 277-291.
74. Arjunan, P.; Nemeria, N.; Brunskill, A.; Chandrasekhar, K.; Sax, M.; Yan, Y.; Jordan, F.; Guest, J. R.; Furey, W. Structure of the pyruvate dehydrogenase multienzyme complex E1 component from Escherichia coli at 1.85 Å resolution. Biochemistry 2002, 41, 5213-5221.
75. Ciszak, E. M.; Korotchkina, L. G.; Dominiak, P. M.; Sidhu, S.; Patel, M. S. Structural basis for flip-flop action of thiamin pyrophosphate-dependent enzymes revealed by human pyruvate dehydrogenase. J. Biol. Chem. 2003, 278, 21240-21246.
76. Fiedler, E.; Thorell, S.; Sandalova, T.; Golbik, R.; Konig, S.; Schneider, G. Snapshot of a key intermediate in enzymatic thiamin catalysis: crystal structure of the alpha-carbanion of (alpha,beta-dihydroxyethyl)-thiamin diphosphate in the active site of transketolase from Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 591-595.
77. Dyda, F.; Furey, W.; Swaminathan, S.; Sax, M.; Farrenkopf, B.; Jordan, F. Catalytic centers in the thiamin diphosphate dependent enzyme pyruvate decarboxylase at 2.4-Å resolution. Biochemistry 1993, 32, 6165-6170.
78. Hasson, M. S.; Muscate, A.; McLeish, M. J.; Polovnikova, L. S.; Gerlt, J. A.; Kenyon, G. L.; Petsko, G. A.; Ringe, D. The crystal structure of benzoylformate decarboxylase at 1.6 Å resolution: diversity of catalytic residues in thiamin diphosphate-dependent enzymes. Biochemistry 1998, 37, 9918-9930.
79. Pang, S. S.; Duggleby, R. G.; Guddat, L. W. Crystal structure of yeast acetohydroxyacid synthase: a target for herbicidal inhibitors. J. Mol. Biol. 2002, 317, 249-262.
80. Muller, Y. A.; Schumacher, G.; Rudolph, R.; Schulz, G. E. The refined structures of a stabilized mutant and of wild-type pyruvate oxidase from Lactobacillus plantarum. J. Mol. Biol 1994, 237, 315-335.
81. Kern, D.; Kern, G.; Neef, H.; Tittmann, K.; Killenberg-Jabs, M.; Wikner, C.; Schneider, G.; Hubner, G. How thiamine diphosphate is activated in enzymes. Science 1997, 275, 67-70.
82. Shuman, S.; Lima, C.D. The polynucleotide ligase and RNA capping enzyme superfamily of covalent nucleotidyltransferases. Curr. Opin. Struct. Biol. 2004, 14, 757-764.
83. Howard, J. B.; Rees, D. C. Structural Basis of Biological Nitrogen Fixation. Chem. Rev. 1996, 96, 2965-2982.
84. Hille, R. The mononuclear molybdenum enzymes. Chem. Rev. 1996, 96, 2757-2816.
85. Hille, R. Molybdenum and tungsten in biology. Trends Biochem. Sci. 2002, 27, 360-367.
86. Fontecilla-Camps, J. C.; Frey, M.; Garcin, E.; Hatchikian, C.; Montet, Y.; Piras, C.; Vernede, X.; Volbeda, A. Hydrogenase: a hydrogen-metabolizing enzyme. What do the crystal structures tell us about its mode of action? Biochimie 1997, 79, 661-666.
87. Chelikani, P.; Fita, I.; Loewen, P. C.Diversity of structures and properties among catalases. Cell Mol. Life Sci. 2004, 61, 192-208.
88. Rogerson, F. M.; Brennan, F. E.; Fuller, P. J. Dissecting mineralocorticoid receptor structure and function. J. Steroid Biochem. Mol Biol. 2003, 85, 389-396.
89. George, A. L., Jr. Inherited disorders of voltage-gated sodium channels. J. Clin. Invest. 2005, 115, 1990-1999.
90. Gormley, K.; Dong, Y.; Sagnella, G. A. Regulation of the epithelial sodium channel by accessory proteins. Biochem. J. 2003, 371, 1-14.
91. Schild, L.; Lu, Y.; Gautschi, I.; Schneeberger, E.; Lifton, R. P.; Rossier, B. C. Identification of a PY motif in the epithelial Na channel subunits as a target sequence for mutations causing channel activation found in Liddle syndrome. Embo. J. 1996, 15, 2381-2387.
92. Marsh, E. N.; Drennan, C.L. Adenosylcobalamin-dependent isomerases: new insights into structure and mechanism. Curr. Opin. Chem. Biol. 2001, 5, 499-505.
93. Kolberg, M.; Strand, K. R.; Graff, P.; Andersson, K. K. Structure, function, and mechanism of ribonucleotide reductases. Biochim. Biophys. Acta 2004, 1699, 1-34.
94. Dunker, A. K.; Brown, C. J.; Lawson, J. D.; Iakoucheva, L. M.; Obradovic, Z. Intrinsic disorder and protein function. Biochemistry 2002, 41, 6573-6582.
95. Marks, F. Protein Phosphorylation; VCH: Weinheim, New York, Basel, Cambridge, Tokyo, 1996.
96. Zor, T.; Mayr, B. M.; Dyson, H. J.; Montminy, M. R.; Wright, P. E. Roles of phosphorylation and helix propensity in the binding of the KIX domain of CREB-binding protein by constitutive (c-Myb) and inducible (CREB) activators. J. Biol. Chem. 2002, 277, 42241-42248.
97. Iakoucheva, L. M.; Radivojac, P.; Brown, C.J.; O'Connor, T. R.; Sikes, J. C.; Obradovic, Z.; Dunker, A. K. The importance of intrinsic disorder for protein phosphorylation. Nucleic Acids Res. 2004, 32, 1037-1049.
98. Obenauer, J. C.; Cantley, L. C.; Yaffe, M. B. Scansite 2.0: Proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res. 2003, 31, 635-3641.
99. Sigalov, A. B. Multichain immune recognition receptor signaling: different players, same game? Trends Immunol. 2004, 25, 583-589.
100. Sigalov, A. Multi-chain immune recognition receptors: spatial organization and signal transduction. Semin. Immunol. 2005, 17, 51-64.
101. Sigalov, A. B. Immune cell signaling: a novel mechanistic model reveals new therapeutic targets. Trends Pharmacol. Sci. 2006, 27, 518-524.
102. Sigalov, A.; Aivazian, D.; Stern, L. Homooligomerization of the cytoplasmic domain of the T cell receptor zeta chain and of other proteins containing the immunoreceptor tyrosine-based activation motif. Biochemistry 2004, 43, 2049-2061.
103. Sigalov, A. B.; Aivazian, D. A.; Uversky, V. N.; Stern, L. J. Lipid-binding activity of intrinsically unstructured cytoplasmic domains of multichain immune recognition receptor signaling subunits. Biochemistry 2006, 45, 15731-15739.
104. Gould, C.; Wong, C.F. Designing specific protein kinase inhibitors: insights from computer simulations and comparative sequence/structure analysis. Pharmacol. Ther. 2002, 93, 169-178.
105. Schulz, G. E. Nucleotide binding proteins. In Molecular Mechanism of Biological Recognition; Balaban, M., Ed.; Elsevier/North-Holland Biomedical Press: New York, 1979 pp 79-94.
106. Han, K. K.; Martinage, A. Post-translational chemical modifications of proteins-III. Current developments in analytical procedures of identification and quantitation of post-translational chemically modified amino acid(s) and its derivatives. Int. J. Biochem. 1993, 25, 957-970.
107. Maurer-Stroh, S.; Eisenhaber, F. Myristoylation of viral and bacterial proteins. Trends Microbiol. 2004, 12, 178-185.
108. Sharom, F. J.; Lehto, M. T. Glycosylphosphatidylinositol-anchored proteins: structure, function, and cleavage by phosphatidylinositol-specific phospholipase C.Biochem. Cell Biol. 2002, 80, 535-549.
109. Ikezawa, H. Glycosylphosphatidylinositol (GPI)-anchored proteins. Biol. Pharm. Bull. 2002, 25, 409-417.
110. Grobe, K.; Ledin, J.; Ringvall, M.; Holmborn, K.; Forsberg, E.; Esko, J. D.; Kjellen, L. Heparan sulfate and development: differential roles of the N-acetylglucosamine N-deacetylase/N-sulfotrans-ferase isozymes. Biochim. Biophys. Acta 2002, 1573, 209-215.
111. Apweiler, R.; Hermjakob, H.; Sharon, N. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim. Biophys. Acta 1999, 1473, 4-8.
112. Ben-Dor, S.; Esterman, N.; Rubin, E.; Sharon, N. Biases and complex patterns in the residues flanking protein N-glycosylation sites. Glycobiology 2004, 14, 95-101.
113. Lutteke, T.; Frank, M.; von der Lieth, C.W. Data mining the protein data bank: automatic detection and assignment of carbohydrate structures. Carbohydr. Res. 2004, 339, 1015-1020.
114. Burnier, J. P.; Borowski, M.; Furie, B. C.; Furie, B. Gamma-carboxyglutamic acid. Mol Cell Biochem. 1981, 39, 191-207.
115. Furie, B.; Bouchard, B. A.; Furie, B. C. Vitamin K-dependent biosynthesis of gamma-carboxyglutamic acid. Blood 1999, 93, 1798-1808.
116. Atkinson, R. A.; Evans, J. S.; Hauschka, P. V.; Levine, B. A.; Meats, R.; Trifirtt, J. T.; Virdi, A. S.; Williams, R. J. Conformational studies of osteocalcin in solution. Eur. J. Biochem. 1995, 232, 515-521.
117. Abraham, G. N.; Podell, D. N. Pyroglutamic acid. Non-metabolic formation, function in proteins and peptides, and characteristics of the enzymes effecting its removal. Mol. Cell. Biochem. 1981, 38, 181-190.
118. Fischer, W. H.; Spiess, J. Identification of a mammalian glutaminyl cyclase converting glutaminyl into pyroglutamyl peptides. Proc. Natl. Acad. Sci. USA. 1987, 84, 3628-3632.
119. Cummins, P. M.; O'Connor, B. Pyroglutamyl peptidase: an overview of the three known enzymatic forms. Biochim. Biophys. Acta 1998, 1429, 1-17.
120. Daily, K. M.; Radivojac, P.; Dunker, A. K. In IEEE Symposium on Computational Intelligence in Bioinformatics and Computational Biology, CIBCB, San Diego, CA, Nov. 14-15, 2005; pp 475-481
121. Kerscher, O.; Felberbaum, R.; Hochstrasser, M. Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu. Rev. Cell Dev. Biol. 2006, 22, 159-180.
122. Huang, D. T.; Walden, H.; Duda, D.; Schulman, B. A. Ubiquitin-like protein activation. Oncogene 2004, 23, 1958-1971.
123. Okeley, N. M.; van der Donk, W. A. Novel cofactors via post-translational modifications of enzyme active sites. Chem. Biol. 2000, 7, R159-171.
124. Mure, M. Tyrosine-derived quinone cofactors. Acc. Chem. Res. 2004, 37, 131-139.
125. Janes, S. M.; Mu, D.; Wemmer, D.; Smith, A. J.; Kaur, S.; Maltby, D.; Burlingame, A. L.; Klinman, J. P. A new redox cofactor in eukaryotic enzymes: 6-hydroxydopa at the active site of bovine serum amine oxidase. Science 1990, 248, 981-987.
126. Brazeau, B. J.; Johnson, B. J.; Wilmot, C.M. Copper-containing amine oxidases. Biogenesis and catalysis; a structural perspective. Arch. Biochem. Biophys. 2004, 428, 22-31.
127. Eklund, H.; Eriksson, M.; Uhlin, U.; Nordlund, P.; Logan, D. Ribonucleotide reductase-structural studies of a radical enzyme. Biol. Chem. 1997, 378, 821-825.
128. Marsh, E. N.; Patwardhan, A.; Huhta, M. S. S-adenosylmethionine radical enzymes. Bioorg. Chem. 2004, 32, 326-340.
129. Firbank, S.; Rogers, M.; Guerrero, R. H.; Dooley, D. M.; Halcrow, M. A.; Phillips, S. E.; Knowles, P. F.; McPherson, M. J. Cofactor processing in galactose oxidase. Biochem. Soc. Symp. 2004, 15-25.
130. Plochocka, D.; Welnicki, M.; Zielenkiewicz, P.; Ostoja-Zagorski, W. Three-dimensional model of the potyviral genome-linked protein. Proc. Natl. Acad. Sci. U.SA. 1996, 93, 12150-12154.
131. Davidson, V. L. Electron transfer in quinoproteins. Arch. Biochem. Biophys. 2004, 428, 32-40.
132. Davidson, V. L. Pyrroloquinoline quinone (PQQ) from methanol dehydrogenase and tryptophan tryptophylquinone (TTQ) from methylamine dehydrogenase. Adv. Protein Chem. 2001, 58, 95-140.
133. Garavelli, J. S. The RESID Database of Protein Modifications as a resource and annotation tool. Proteomics 2004, 4, 1527-1533.
134. Michel, H.; Behr, J.; Harrenga, A.; Kannt, A. Cytochrome c oxidase: structure and spectroscopy. Annu. Rev. Biophys. Biomol. Struct. 1998, 27, 329-356.
135. Farriol-Mathis, N.; Garavelli, J. S.; Boeckmann, B.; Duvaud, S.; Gasteiger, E.; Gateau, A.; Veuthey, A. L.; Bairoch, A. Annotation of post-translational modifications in the Swiss-Prot knowledge base. Proteomics 2004, 4, 1537-1550.
136. Wiederanders, B. Structure-function relationships in class CA1 cysteine peptidase propeptides. Acta Biochim. Pol. 2003, 50, 691-713.
137. Bernstein, N. K.; Cherney, M. M.; Yowell, C.A.; Dame, J. B.; James, M. N. Structural insights into the activation of P. vivax plasmepsin. J. Mol. Biol. 2003, 329, 505-524.
138. Seipelt, J.; Guarne, A.; Bergmann, E.; James, M.; Sommergruber, W.; Fita, I.; Skern, T. The structures of picornaviral proteinases. Virus Res. 1999, 62, 159-168.
139. Tate, S. S.; Meister, A. gamma-Glutamyl transpeptidase: catalytic, structural and functional aspects. Mol. Cell. Biochem. 1981, 39, 357-368.
140. Okada, T.; Suzuki, H.; Wada, K.; Kumagai, H.; Fukuyama, K. Crystal structures of gamma-glutamyltranspeptidase from Escherichia coli, a key enzyme in glutathione metabolism, and its reaction intermediate. Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 6471-6476.
141. Anraku, Y.; Mizutani, R.; Satow, Y. Protein splicing: its discovery and structural insight into novel chemical mechanisms. IUBMB Life 2005, 57, 563-574.
142. Perler, F. B. Protein splicing mechanisms and applications. IUBMB Life 2005, 57, 469-476.
143. Kane, P. M.; Yamashiro, C. T.; Wolczyk, D. F.; Neff, N.; Goebl, M.; Stevens, T. H. Protein splicing converts the yeast TFP1 gene product to the 69-kD subunit of the vacuolar H(+)-adenosine triphosphatase. Science 1990, 250, 651-657.
144. Davis, E. O.; Jenner, P. J.; Brooks, P. C.; Colston, M. J.; Sedgwick, S. G. Protein splicing in the maturation of M. tuberculosis recA protein: a mechanism for tolerating a novel class of intervening sequence. Cell 1992, 71, 201-210.
145. Hodges, R. A.; Perler, F. B.; Noren, C.J.; Jack, W. E. Protein splicing removes intervening sequences in an archaea DNA polymerase. Nucleic Acids Res. 1992, 20, 6153-6157.
146. Kawasaki, M.; Makino, S.; Matsuzawa, H.; Satow, Y.; Ohya, Y.; Anraku, Y. Folding-dependent in vitro protein splicing of the Saccharomyces cerevisiae VMA1 protozyme. Biochem. Biophys. Res. Commun. 1996, 222, 827-832.
147. Gogarten, J. P.; Senejani, A. G.; Zhaxybayeva, O.; Olendzenski, L.; Hilario, E. Inteins: structure, function, and evolution. Annu. Rev. Microbiol. 2002, 56, 263-287.
148. Clarke, N. D. A proposed mechanism for the self-splicing of proteins. Proc. Natl. Acad. Sci. U.SA. 1994, 91, 11084-11088.
149. Xu, M. Q.; Perler, F. B. The mechanism of protein splicing and its modulation by mutation. EMBO J. 1996, 15, 5146-5153.
150. Perler, F. B. InBase: the Intein Database. Nucleic Adas Res. 2002, 30, 383-384.
151. Dalle-Donne, I.; Giustarini, D.; Colombo, R.; Rossi, R.; Milzani, A. Protein carbonylation in human diseases. Trends Mol. Med. 2003, 9, 169-176.
152. Stadtman, E. R. Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. Annu. Rev. Biochem. 1993, 62, 797-821.
153. Vogt, W. Oxidation of methionyl residues in proteins: tools, targets, and reversal. Free Radical Biol. Med. 1995, 18, 93-105.
154. Moskovitz, J.; Weissbach, H.; Brot, N. Cloning the expression of a mammalian gene involved in the reduction of methionine sulfoxide residues in proteins. Proc. Natl. Acad. Sci. U.SA. 1996, 93, 2095-2099.
155. Ghezzi, P. Oxidoreduction of protein thiols in redox regulation. Biochem. Soc. Trans. 2005, 33, 1378-1381.
156. Shiba, T.; Mizote, H.; Kaneko, T.; Nakajima, T.; Kakimoto, Y. Hypusine, a new amino acid occurring in bovine brain. Isolation and structural determination. Biochim. Biophys. Acta 1971, 244, 523-531.
157. Park, M. H.; Cooper, H. L.; Folk, J. E. The biosynthesis of protein-bound hypusine (N epsilon-(4-amino-2-hydroxybutyl)lysine). Lysine as the amino acid precursor and the intermediate role of deoxyhypusine (N epsilon-(4-aminobutyl) lysine). J. Biol. Chem. 1982, 257, 7217-7222.
158. Park, M. H. The post-translational synthesis of a polyamine-derived amino acid, hypusine, in the eukaryotic translation initiation factor 5A (eIF5A). J. Biochem. (Tokyo) 2006, 139, 161-169.
159. Iakoucheva, L. M.; Brown, C.J.; Lawson, J. D.; Obradovic, Z.; Dunker, A. K. Intrinsic disorder in cell-signaling and cancer-associated proteins. J. Mol. Biol. 2002, 323, 573-584.
160. Lee, R; Mok, K. H.; Muhandiram, R.; Park, K. H.; Suk, J. E.; Kim, D. H.; Chang, J.; Sung, Y. C.; Choi, K. Y.; Han, K. H. Local structural elements in the mostly unstructured transcriptional activation domain of human p53. J. Biol. Chem. 2000, 275, 29426-29432.
161. Adkins, J. N.; Lumb, K. J. Intrinsic structural disorder and sequence features of the cell cycle inhibitor p57Kip2. Proteins 2002, 46, 1-7.
162. Chang, B. S.; Minn, A. J.; Muchmore, S. W.; Fesik, S. W.; Thompson, C. B. Identification of a novel regulatory domain in Bcl-X(L) and Bcl-2. EMBO J. 1997, 16, 968-977.
163. Campbell, K. M.; Terrell, A. R.; Laybourn, P. J.; Lumb, K. J. Intrinsic structural disorder of the C-terminal activation domain from the bZIP transcription factor Fos. Biochemistry 2000, 39, 2708-2713.
164. Sanchez-Puig, N.; Veprintsev, D. B.; Fersht, A. R. Human full-length Securin is a natively unfolded protein. Protein Sci. 2005, 14, 1410-1418.
165. Mark, W. Y.; Liao, J. C.; Lu, Y.; Ayed, A.; Laister, R.; Szymczyna, B.; Chakrabartty, A.; Arrowsmith, C.H. Characterization of segments from the central region of BRCA1: an intrinsically disordered scaffold for multiple protein-protein and protein-DNA interactions? J. Mol. Biol. 2005, 345, 275-287.
166. Uversky, V. N.; Roman, A.; Oldfield, C.J.; Dunker, A. K. Protein intrinsic disorder and human papillomaviruses: Increased amount of disorder in E6 and E7 oncoproteins from high risk HPVs. J. Proteome Res. 2006, 5, 1829-1842.
167. Burgess, B. R.; Schuck, P.; Garboczi, D. N. Dissection of merozoite surface protein 3, a representative of a family of Plasmodium falciparum surface proteins, reveals an oligomeric and highly elongated molecule. J. Biol. Chem. 2005, 280, 37236-37245.
168. Nair, M.; Hinds, M. G.; Coley, A. M.; Hodder, A. N.; Foley, M.; Anders, R. F.; Norton, R. S. Structure of domain III of the blood-stage malaria vaccine candidate, Plasmodium falciparum apical membrane antigen 1 (AMA1). J. Mol. Biol. 2002, 322, 741-753.
169. Feng, Z. P.; Keizer, D. W.; Stevenson, R. A.; Yao, S.; Babon, J. I.; Murphy, V. J.; Anders, R. F.; Norton, R. S. Structure and interdomain interactions of domain II from the blood-stage malarial protein, apical membrane antigen 1. J. Mol. Biol. 2005, 350, 641-656.
170. Thomson, L. M.; Lamont, D. J.; Mehlert, A.; Barry, J. D.; Ferguson, M. A. Partial structure of glutamic acid and alanine-rich protein, a major surface glycoprotein of the insect stages of Trypanosoma congolense. J. Biol. Chem. 2002, 277, 48899-48904.
171. Treumann, A.; Zitzmann, N.; Hulsmeier, A.; Prescott, A. R.; Almond, A.; Sheehan, J.; Ferguson, M. A. Structural characterisation of two forms of procyclic acidic repetitive protein expressed by procyclic forms of Trypanosoma brucei. J. Mol. Biol. 1997, 269, 529-547.
172. Butikofer, P.; Ruepp, S.; Boschung, M.; Roditi, I. 'GPEET' procyclin is the major surface protein of procyclic culture forms of Trypanosoma brucei brucei strain 427. Biochem. J. 1997, 326 (Pt. 2), 415-423.
173. Acosta-Serrano, A.; Cole, R. N.; Mehlert, A.; Lee, M. G.; Ferguson, M. A.; Englund, P. T. The procyclin repertoire of Trypanosoma brucei. Identification and structural characterization of the Glu-Pro-rich polypeptides. J. Biol. Chem. 1999, 274, 29763-29771.
174. Turner, B. G.; Summers, M. F. Structural biology of HIV. J. Mol. Biol. 1999, 285, 1-32.
175. Lee, B. M.; De Guzman, R. N.; Turner, B. G.; Tjandra, N.; Summers, M. F. Dynamical behavior of the HIV-1 nucleocapsid protein. J. Mol. Biol. 1998, 279, 633-649.
176. Tan, R.; Frankel, A. D. Costabilization of peptide and RNA structure in an HIV Rev peptide-RRE complex. Biochemistry 1994, 33, 14579-14585.
177. Battiste, J. L.; Tan, R.; Frankel, A. D.; Williamson, J. R. Assignment and modeling of the Rev Response Element RNA bound to a Rev peptide using 13C-heteronuclear NMR. J. Biomol NMR 1995, 6, 375-389.
178. Bayer, P.; Kraft, M.; Ejchart, A.; Westendorp, M.; Frank, R.; Rosch, P. Structural studies of HIV-1 Tat protein. J. Mol Biol. 1995, 247, 529-535.
179. Shojania, S.; O'Neil, J. D. HIV-1 Tat is a natively unfolded protein: the solution conformation and dynamics of reduced HIV-1 Tat-(1-72) by NMR spectroscopy. J. Biol. Chem. 2006, 281, 8347-8356.
180. Zaitseva, M.; Peden, K.; Golding, H. HIV coreceptors: role of structure, posttranslational modifications, and internalization in viral-cell fusion and as targets for entry inhibitors. Biochim. Biophys. Acta 2003, 1614, 51-61.
181. Kwong, P. D.; Wyatt, R.; Robinson, J.; Sweet, R. W.; Sodroski, J.; Hendrickson, W. A. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 1998, 393, 648-659.
182. Guilhaudis, L.; Jacobs, A.; Caffrey, M. Solution structure of the HIV gp120 C5 domain. Eur. J. Biochem. 2002, 269, 4860-4867.
183. Sabag, A. D.; Dagan, O.; Avraham, K. B. Connexins in hearing loss: a comprehensive overview. J. Basic Clin. Physiol Pharmacol. 2005, 16, 101-116.
184. Duffy, H. S.; Sorgen, P. L.; Girvin, M. E.; O'Donnell, P.; Coombs, W.; Taffet, S. M.; Delmar, M.; Spray, D. C. pH-dependent intramolecular binding and structure involving Cx43 cytoplasmic domains. J. Biol. Chem. 2002, 277, 36706-36714.
185. Sosinsky, G. E.; Nicholson, B. J. Structural organization of gap junction channels. Biochim. Biophys. Acta 2005, 1711, 99-125.
186. Sorgen, P. L.; Duffy, H. S.; Sahoo, P.; Coombs, W.; Delmar, M.; Spray, D. C.Structural changes in the carboxyl terminus of the gap junction protein connexin43 indicates signaling between binding domains for c-Src and zonula occludens-1. J. Biol. Chem. 2004, 279, 54695-54701.
187. Giepmans, B. N. Gap junctions and connexin-interacting proteins. Cardiovasc. Res. 2004, 62, 233-245.
188. Matsuzawa, Y. The metabolic syndrome and adipocytokines. FEBS Lett. 2006, 580, 2917-2921.
189. Cheng, Y.; Le Gall, T.; Oldfield, C.J.; Dunker, A. K.; Uversky, V. N. Abundance of intrinsic disorder in proteins associated with cardiovascular disease. Biochemistry 2006, 45, 10448-10460.
190. Oldfield, C.J.; Cheng, Y.; Cortese, M. S.; Romero, P.; Uversky, V. N.; Dunker, A. K. Coupled folding and binding with α-helix-forming molecular recognition elements. Biochemistry 2005, 44, 12454-12470.
191. Oetting, W. S.; King, R. A. Molecular basis of albinism: mutations and polymorphisms of pigmentation genes associated with albinism. Hum. Mutat. 1999, 13, 99-115.
192. Cooksey, C.J.; Garratt, P. J.; Land, E. J.; Pavel, S.; Ramsden, C.A.; Riley, P. A.; Smit, N. P. Evidence of the indirect formation of the catecholic intermediate substrate responsible for the autoactivation kinetics of tyrosinase. J. Biol. Chem. 1997, 272, 26226-26235.
193. Hearing, V. J.; Jimenez, M. Mammalian tyrosinase-the critical regulatory control point in melanocyte pigmentation. Int. J. Biochem. 1987, 19, 1141-1147.
194. van Gelder, C.W.; Flurkey, W. H.; Wichers, H. J. Sequence and structural features of plant and fungal tyrosinases. Phytochemistry 1997, 45, 1309-1323.
195. Donne, D. G.; Viles, J. H.; Groth, D.; Mehlhom, I.; James, T. L.; Cohen, F. E.; Prusiner, S. B.; Wright, P. E.; Dyson, H. J. Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 13452-13457.
196. Riek, R.; Hornemann, S.; Wider, G.; Billeter, M.; Glockshuber, R.; Wuthrich, K. NMR structure of the mouse prion protein domain PrP(121-321). Nature 1996, 382, 180-182.
197. 2+ binding sites in the N-terminal domain of the prion protein by EPR and CD spectroscopy. Biochemistry 2000, 39, 13760-13771.
198. Burns, C.S.; Aronoff-Spencer, E.; Dunham, C.M.; Lario, P.; Avdievich, N. I.; Antholine, W. E.; Olmstead, M. M.; Vrielink, A.; Gerfen, G. J.; Peisach, J.; Scott, W. G.; Millhauser, G. L. Molecular features of the copper binding sites in the octarepeat domain of the prion protein. Biochemistry 2002, 41, 3991-4001.
199. Bullock, A. N.; Fersht, A. R. Rescuing the function of mutant p53. Nat. Rev. Cancer 2001, 1 68-76.
200. Hainaut, P.; Hollstein, M. p53 and human cancer: the first ten thousand mutations. Adv. Cancer Res. 2000, 77, 81-137.
201. Dobson, C.M. Protein misfolding, evolution and disease. Trends Biochem. Sci. 1999, 24, 329-332.
202. Dobson, C.M. Principles of protein folding, misfolding and aggregation. Semin. Cell Dev. Biol. 2004, 15, 3-16.
203. Uversky, V. N.; Fink, A. L. Conformational constraints for amyloid fibrillation: the importance of being unfolded. Biochim. Biophys. Acta 2004, 1698, 131-153.
204. Uversky, V. N. A protein-chameleon: conformational plasticity of alpha-synuclein, a disordered protein involved in neurode-generative disorders. J. Blomol. Struct. Dyn. 2003, 21, 211-234.
205. Kruger, R.; Kuhn, W.; Muller, T.; Woitalla, D.; Graeber, M.; Kosel, S.; Przuntek, H.; Epplen, J. T.; Schols, L.; Riess, O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 1998, 18, 106-108.
206. Zarranz, J. J.; Alegre, J.; Gomez-Esteban, J. C.; Lezcano, E.; Ros, R.; Ampuero, I.; Vidal, L.; Hoenicka, J.; Rodriguez, O.; Atares, B.; Llorens, V.; Gomez, Tortosa, E.; del Ser, T.; Munoz, D. G.; de Yebenes, J. G. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 2004, 55, 164-173.
207. Polymeropoulos, M. H.; Lavedan, C.; Leroy, E.; Ide, S. E.; Dehejia, A.; Dutra, A.; Pike, B.; Root, H.; Rubenstein, J.; Boyer, R.; Stenroos, E. S.; Chandrasekharappa, S.; Athanassiadou, A.; Papapetropoulos, T.; Johnson, W. G.; Lazzarini, A. M.; Duvoisin, R. C.; Di, Iorio, G.; Golbe, L. I.; Nussbaum, R. L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997, 276, 2045-2047.
208. Li, J.; Uversky, V. N.; Fink, A. L. Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human α-synuclein. Biochemistry 2001, 40, 11604-11613.